Demant AS

DEMANT: XCSE (DNK)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
#d<LOCK|$<j?LOCK|&H^y?G

Demant Earnings: Volume Decline Continues in Hearing Aids, but Market Share Has Stabilized

Demant reported second-half 2024 results and 2025 guidance, which suggests stabilization of the underlying negative trends in the hearing aids segment. Shares are down roughly 5% on the news.

Sponsor Center